Aliases: F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74
Chromosome No: 2
Chromosome Band: 2p23.3
Genetic Category: Rare single gene variant
ASD Reports: 4
Recent Reports: 1
Annotated variants: 7
Associated CNVs: 4
Evidence score: 3
Associated Disorders: |
|
Relevance to Autism
A de novo missense variant in the NCOA1 gene was identified in an ASD proband from the Simons Simplex Collection (Iossifov et al., 2014). Two de novo variants (a nonsense variant and a second missense variant) in this gene were subsequently identified in ASD probands from the Autism Sequencing Consortium, as were two protein-truncating variants in case samples from the Danish iPSYCH study (Satterstrom et al., 2020). TADA analysis of de novo variants from the Simons Simplex Collection and the Autism Sequencing Consortium and protein-truncating variants from iPSYCH in Satterstrom et al., 2020 identified NCOA1 as a candidate gene with a false discovery rate (FDR) between 0.05 and 0.1 (0.05 < FDR 0.1).
Molecular Function
The protein encoded by this gene acts as a transcriptional coactivator for steroid and nuclear hormone receptors. It is a member of the p160/steroid receptor coactivator (SRC) family and like other family members has histone acetyltransferase activity and contains a nuclear localization signal, as well as bHLH and PAS domains. The product of this gene binds nuclear receptors directly and stimulates the transcriptional activities in a hormone-dependent fashion.